These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23001065)

  • 1. Aggregate-data estimation of an individual patient data linear random effects meta-analysis with a patient covariate-treatment interaction term.
    Kovalchik SA
    Biostatistics; 2013 Apr; 14(2):273-83. PubMed ID: 23001065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis methods and models with applications in evaluation of cholesterol-lowering drugs.
    Chen MH; Ibrahim JG; Shah AK; Lin J; Yao H
    Stat Med; 2012 Dec; 31(28):3597-616. PubMed ID: 22829358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS).
    de Groot E; Jukema JW; Montauban van Swijndregt AD; Zwinderman AH; Ackerstaff RG; van der Steen AF; Bom N; Lie KI; Bruschke AV
    J Am Coll Cardiol; 1998 Jun; 31(7):1561-7. PubMed ID: 9626835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [REGRESS [The Regression Growth Evaluation Statin Study]].
    Hayashi K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():422-6. PubMed ID: 11347107
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study.
    Hague WE; Simes J; Kirby A; Keech AC; White HD; Hunt D; Nestel PJ; Colquhoun DM; Pater H; Stewart RA; Sullivan DR; Thompson PL; West M; Glasziou PP; Tonkin AM;
    Circulation; 2016 May; 133(19):1851-60. PubMed ID: 27016105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of controlled direct effects in time-varying treatments using structural nested mean models: application to a primary prevention trial for coronary events with pravastatin.
    Shinozaki T; Matsuyama Y; Ohashi Y
    Stat Med; 2014 Aug; 33(18):3214-28. PubMed ID: 24706589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using aggregate data to estimate the standard error of a treatment-covariate interaction in an individual patient data meta-analysis.
    Kovalchik SA; Cumberland WG
    Biom J; 2012 May; 54(3):370-84. PubMed ID: 22685003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials.
    Kang S; Liu Y; Liu XB
    Clin Ther; 2013 Aug; 35(8):1125-36. PubMed ID: 23932462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta-analysis of clinical trials.
    Sahebkar A; Simental-Mendía LE; Guerrero-Romero F; Golledge J; Watts GF
    Diabetes Obes Metab; 2015 Nov; 17(11):1042-55. PubMed ID: 26183252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-stage random effects meta-analysis using linear mixed models for aggregate continuous outcome data.
    Papadimitropoulou K; Stijnen T; Dekkers OM; le Cessie S
    Res Synth Methods; 2019 Sep; 10(3):360-375. PubMed ID: 30523676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG CoA reduction in patients with average cholesterol concentrations.
    Braunwald E; Sacks FM; Pfeffer MA; Ridker PM
    Clin Chem; 2011 Jul; 57(7):1072-3. PubMed ID: 21519035
    [No Abstract]   [Full Text] [Related]  

  • 12. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events.
    Boekholdt SM; Agema WR; Peters RJ; Zwinderman AH; van der Wall EE; Reitsma PH; Kastelein JJ; Jukema JW;
    Circulation; 2003 May; 107(19):2416-21. PubMed ID: 12742999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM; Sacks FM; Jukema JW; Shepherd J; Freeman DJ; McMahon AD; Cambien F; Nicaud V; de Grooth GJ; Talmud PJ; Humphries SE; Miller GJ; Eiriksdottir G; Gudnason V; Kauma H; Kakko S; Savolainen MJ; Arca M; Montali A; Liu S; Lanz HJ; Zwinderman AH; Kuivenhoven JA; Kastelein JJ
    Circulation; 2005 Jan; 111(3):278-87. PubMed ID: 15655129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random effects meta-analysis: Coverage performance of 95% confidence and prediction intervals following REML estimation.
    Partlett C; Riley RD
    Stat Med; 2017 Jan; 36(2):301-317. PubMed ID: 27714841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective meta-analysis of cholesterol-lowering studies: the Prospective Pravastatin Pooling (PPP) Project and the Cholesterol Treatment Trialists (CTT) Collaboration.
    Simes RJ
    Am J Cardiol; 1995 Sep; 76(9):122C-126C. PubMed ID: 7572681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study.
    de Groot E; Jukema JW; van Boven AJ; Reiber JH; Zwinderman AH; Lie KI; Ackerstaff RA; Bruschke AV
    Am J Cardiol; 1995 Sep; 76(9):40C-46C. PubMed ID: 7572685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of a continuous outcome combining individual patient data and aggregate data: a method based on simulated individual patient data.
    Yamaguchi Y; Sakamoto W; Goto M; Staessen JA; Wang J; Gueyffier F; Riley RD
    Res Synth Methods; 2014 Dec; 5(4):322-51. PubMed ID: 26052956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-stage individual participant data meta-analysis models: estimation of treatment-covariate interactions must avoid ecological bias by separating out within-trial and across-trial information.
    Hua H; Burke DL; Crowther MJ; Ensor J; Tudur Smith C; Riley RD
    Stat Med; 2017 Feb; 36(5):772-789. PubMed ID: 27910122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of one-stage vs two-stage individual patient data meta-analysis methods: A simulation study.
    Kontopantelis E
    Res Synth Methods; 2018 Sep; 9(3):417-430. PubMed ID: 29786975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and mortality.
    Muntwyler J; Gutzwiller F
    Eur Heart J; 2002 Feb; 23(3):183-4. PubMed ID: 11792128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.